Top Markets
#1 Islamic Coin Islamic Coin +154.37%
#2 PulseChain PulseChain +49.10%
#3 BOOK OF MEME BOOK OF MEME +32.79%
#4 DogBull DogBull +31.83%
#5 Bio Protocol Bio Protocol +20.55%
#6 Ergo Ergo +19.21%
#7 Janction Janction +18.28%
#8 edgeX edgeX +16.66%
#9 RedStone RedStone +14.80%
#10 Four Four +14.59%
Coin of the day
Islamic Coin Islamic Coin
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Prince Pharmaceutical Co., Ltd. Prince Pharmaceutical Co., Ltd.

Prince Pharmaceutical Co., Ltd.

6935
Classifica tra le azioni #27309
Prince Pharmaceutical Co., Ltd. operates in the production and global sale of... Prince Pharmaceutical Co., Ltd. operates in the production and global sale of active pharmaceutical ingredients (APIs), primarily focusing on vitamin B1. Its market presence extends across Taiwan, Japan, Korea, and other international territories. The company's product portfolio also encompasses a variety of consumer health items and general medicines. These offerings include popular formulations such as vitamin C tablets and vitamin B complex tablets, alongside specialized supplements like natto and rhodiola extract capsules, probiotic sachets, and various plant extract capsules. In addition to vitamin B1, Prince Pharmaceutical supplies a comprehensive array of other APIs, notably felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potassium cresolsulfonate, fusultiamine hydrochloride, and fursultiamine. The company's distribution network specifically includes countries within Spain and the wider European continent. Established in 1962, Prince Pharmaceutical Co., Ltd. is based in Yunlin County, Taiwan.
Prezzo delle azioni
$0.89991249
Capitalizzazione di mercato
$33.67M
Variazione (1 giorno)
-0.35%
Variazione (1 anno)
7.33%
Paese
TW
Scambia Prince Pharmaceutical Co., Ltd. (6935)

Categoria

Healthcare
Ricavi di Prince Pharmaceutical Co., Ltd. (6935)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Prince Pharmaceutical Co., Ltd., i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Prince Pharmaceutical Co., Ltd. da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN